Validation Study of CONTEC08C Electronic Sphygmomanometer
Validation of the CONTEC08C Oscillometric Blood Pressure Monitor in General Population According to the AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018)
1 other identifier
interventional
100
1 country
1
Brief Summary
The purpose of this study is to assess the accuracy of the CONTEC08C automated oscillometric upper-arm sphygmomanometer in the general population for clinical use according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension /International Organization for Standardization (AAMI/ESH/ISO) Universal Standard (ISO 81060-2:2018).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 25, 2024
CompletedFirst Submitted
Initial submission to the registry
June 8, 2024
CompletedFirst Posted
Study publicly available on registry
June 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedJune 24, 2024
June 1, 2024
2 months
June 8, 2024
June 20, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Blood pressure measurement data
Systolic Blood Pressure and Diastolic Blood Pressure
30mintues
Study Arms (1)
CONTEC08C and mercury sphygmomanometer
EXPERIMENTALBlood Pressure Measurement with the CONTEC08C Oscillometric Sphygmomanometer (CONTEC08C) and with Mercury Sphygmomanometer
Interventions
The blood pressure measurement was taken simultaneously by two observers using mercury sphygmomanometer and by a supervisor using the tested device, CONTEC08C.
Eligibility Criteria
You may qualify if:
- Subjects aged 12 to 79 years
- Subjects voluntarily participate in the clinical trial and sign the informed consent.
You may not qualify if:
- Subjects with cardiac arrhythmias;
- Pregnancy;
- Poor quality Korotkoff sounds;
- Subject with an arm injury incompatible with the use of a cuff-based sphygmomanometer;
- Other conditions that the investigator considers ineligible for clinical trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chinese Academy of Medical Sciences,Fuwai Hospital
Beijing, Beijing Municipality, 100037, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ying Lou, MD
Chinese Academy of Medical Sciences, Fuwai Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
June 8, 2024
First Posted
June 13, 2024
Study Start
May 25, 2024
Primary Completion
July 25, 2024
Study Completion
August 1, 2024
Last Updated
June 24, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share